Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance.
- NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_assertion description "[Overexpression of PPARdelta or activation of PPARdelta by its pharmacological ligand, GW501516, at low doses (0.5-50 nM) promoted the growth of three human cholangiocarcinoma cell lines (CCLP1, HuCCT1, and SG231).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance.
- NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_assertion evidence source_evidence_literature NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance.
- NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_assertion SIO_000772 16966336 NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance.
- NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_assertion wasDerivedFrom befree-2016 NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance.
- NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_assertion wasGeneratedBy ECO_0000203 NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance.
- befree-2016 importedOn "2016-02-19" NP568838.RAKDc6u0gofbCv2W5k_ryO9QXqYA68jwF3B-Cxrqp8Gbc130_provenance.